WHO Drug Information, Vol. 17, No. 4, 2003                                                  Recommended INN: List 50



International Nonproprietary Names for
Pharmaceutical Substances (INN)
RECOMMENDED International Nonproprietary Names: List 50
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution
EB15.R7); 1969, 173, 10 (Resolution EB43.R9)], the following names are selected as Recommended International
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not
imply any recommendation of the use of the substance in medicine or pharmacy.

Lists of Proposed (1–85) and Recommended (1–45) International Nonproprietary Names can be found in Cumulative List
No. 10, 2002 (available in CD-ROM only).



Dénominations communes internationales
des Substances pharmaceutiques (DCI)
Dénominations communes internationales RECOMMANDÉES :
Liste 50
Il est notifié que, conformément aux dispositions du paragraphe 7 de la Procédure à suivre en vue du choix de
Dénominations communes internationales recommandées pour les Substances pharmaceutiques [Actes off. Org. mond.
Santé, 1955, 60, 3 (résolution EB15.R7); 1969, 173, 10 (résolution EB43.R9)] les dénominations ci-dessous sont choisises
par l’Organisation mondiale de la Santé en tant que dénominations communes internationales recommandées. L’inclusion
d’une dénomination dans les listes de DCI recommandées n’implique aucune recommandation en vue de l’utilisation de la
substance correspondante en médecine ou en pharmacie.

On trouvera d’autres listes de Dénominations communes internationales proposées (1–85) et recommandées (1–45) dans
la Liste récapitulative No. 10, 2002 (disponible sur CD-ROM seulement).



Denominaciones Comunes Internacionales
para las Sustancias Farmacéuticas (DCI)
Denominaciones Comunes Internacionales RECOMENDADAS :
Lista 50
De conformidad con lo que dispone el párrafo 7 del Procedimiento de Selección de Denominaciones Comunes
Internacionales Recomendadas para las Sustancias Farmacéuticas [Act. Of. Mund. Salud, 1955, 60, 3 (Resolución
EB15.R7); 1969, 173, 10 (Resolución EB43.R9)], se comunica por el presente anuncio que las denominaciones que a
continuación se expresan han sido seleccionadas como Denominaciones Comunes Internacionales Recomendadas. La
inclusión de una denominación en las listas de las Denominaciones Comunes Recomendadas no supone recomendación
alguna en favor del empleo de la sustancia respectiva en medicina o en farmacia.

Las listas de Denominaciones Comunes Internacionales Propuestas (1–85) y Recomendadas (1–45) se encuentran
reunidas en Cumulative List No. 10, 2002 (disponible sólo en CD-ROM).




                                                                                                                    267
Recommended INN: List 50                                               WHO Drug Information, Vol. 17, No. 4, 2003




 Latin, English, French, Spanish:
 Recommended INN                    Chemical name or description; Molecular formula; Graphic formula

 DCI Recommandée                    Nom chimique ou description; Formule brute; Formule développée

 DCI Recomendada                    Nombre químico o descripción; Fórmula empírica; Fórmula desarrollada




 acidum arundicum
 arundic acid                              (2R)-2-propyloctanoic acid

 acide arundique                           (-)-acide (2R)-2-propyloctanoïque

 ácido arúndico                            ácido (2R)-2-propiloctanoico

                                           C11H22O2

                                                                      CH3
                                                                  H
                                            H3C
                                                                   CO2H


 acidum salcaprozicum
 salcaprozic acid                          8-(2-hydroxybenzamido)octanoic acid

 acide salcaprozique                       acide 8-[(2-hydroxybenzoyl)amino]octanoïque

 ácido salcaprózico                        ácido 8-(2-hidroxibenzamido]octanoico

                                           C15H21NO4

                                                      O

                                                           N                    CO2H
                                                           H
                                                      OH

 alvocidibum
 alvocidib                                 (-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R*,4S*)-3-hydroxy-
                                           1-methyl-4-piperidyl]-4H-chromen-4-one

 alvocidib                                 (-)-2-(2-chlorophényl)-5,7-dihydroxy-8-[(3R*,4S*)-3-hydroxy-
                                           1-méthylpipéridin-4-yl]-4H-1-benzopyran-4-one

 alvocidib                                 (-)-2-(2-clorofenil)-5,7-dihidroxi-8-[(3R*,4S*)-3-hidroxi-
                                           1-metilpiperidin-4-il]-4H-cromen-4-ona




268
WHO Drug Information, Vol. 17, No. 4, 2003                                                         Recommended INN: List 50



                                             C21H20ClNO5

                                             H3C
                                                   N
                                                                H
                                                                OH Cl
                                                                                      or enantiomer
                                                            H
                                             HO                  O                    ou énantiomère
                                                                                      o enantiómero



                                                       OH        O

 anatibantum
 anatibant                                   (2S)-N-[3-(4-carbamimidoylbenzamido)propyl]-1-{2,4-dichloro-
                                             3-[(2,4-dimethyl-8-quinolyloxy)methyl]phenylsulfonyl}pyrrolidine-
                                             2-carboxamide

 anatibant                                   (2S)-N-[3-[(4-carbamimidoylbenzoyl)amino]propyl]-1-[[2,4-dichloro-
                                             3-[[(2,4-diméthylquinoléin-8-yl)oxy]méthyl]phényl]sulfonyl]pyrrolidine-
                                             2-carboxamide

 anatibant                                   (2S)-N-{3-[(4-carbamimidoilbenzamido]propil}-1-{2,4-dicloro-
                                             3-[(2,4-dimetilquinolein-8-iloxi]metill]fenil]sulfonil}pirrolidina-
                                             2-carboxamida

                                             C34H36Cl2N6O5S

                                                                Cl
                                                                                   O                                 NH
                                                            O
                                                                                  S O
                                                                                         H                                NH2
                                                                           Cl     N          H         H
                                                            N                                N         N

                                             H3C                    CH3                  O                 O


 ardenerminum
 ardenermin                                  B-lymphocte stimulator-(134-285)-peptide

 ardénermine                                 peptide-(134-285)-stimulateur du lymphocyte-B humain

 ardenermina                                 péptido-(134-285)-estimulante del linfocito-B humano

                                             [C770H1205N193O232S5]6

                                                                                AVQGPEE      TVTQDCLQLI        ADSETPTIQK
                                              GSYTFVPWLL                  SFKRGSALEE         KENKILVKET        GYFFIYGQVL
                                              YTDKTYAMGH                  LIQRKKVHVF         GDELSLVTLF        RCIQNMPETL
                                              PNNSCYSAGI                  AKLEEGDELQ         LAIPRENAQI        SLDGDVTFFG
                                               ALKLL                                                                            6




                                                                                                                            269
Recommended INN: List 50                                 WHO Drug Information, Vol. 17, No. 4, 2003




 arimoclomolum
 arimoclomol               N-[(2R)-2-hydroxy-3-(1-piperidyl)propoxy]pyridine-3-carboximidoyl
                           chloride, 1-oxide

 arimoclomol               1-oxyde du chlorure de N-[(2R)-2-hydroxy-3-(pipéridin-
                           1-yl)propoxy]pyridin-3-carboximidoyle

 arimoclomol               1-óxido del cloruro de (Z)-N-[(2R)-2-hidroxi-
                           3-(1-piperidil)propoxi]piridina-3-carboximidoilo

                           C14H20ClN3O3

                              O-
                              N+                     H OH
                                             O              N
                                         N

                                    Cl

 aselizumabum
 aselizumab                immunoglobulin G4, anti-(L-selectin) (human-mouse monoclonal
                           HuDreg-55 heavy chain), disulfide with human-mouse monoclonal
                           HuDreg-55 light chain, dimer

 asélizumab                immunoglobuline G4, anti-(sélectine L) (chaîne lourde de l’anticorps
                           monoclonal de souris HuDreg-55 humanisé), dimère du disulfure
                           avec la chaîne légère de l’anticorps monoclonal de souris HuDreg-
                           55 humanisé

 aselizumab                inmunoglobulina G4, anti-(selectina L) (cadena pesada del
                           anticuerpo monoclonal humanizado de ratón HuDreg-55), dímero del
                           disulfuro con la cadena ligera del anticuerpo monoclonal
                           humanizado de ratón HuDreg-55




 asoprisnili ecamas
 asoprisnil ecamate        11β-{4-[(E)-(ethylcarbamoyloxyimino)methyl]phenyl}-17β-methoxy-
                           17α-(methoxymethyl)estra-4,9-dien-3-one

 écamate d'asoprisnil      11β-[4-[(E)-[[(éthylcarbamoyl)oxy]imino]méthyl]phényl]-17β-méthoxy-
                           17-(méthoxyméthyl)estra-4,9-dién-3-one

 ecamato de asoprisnilo    11β-{4-[(E)-[[(etilcarbamoil)oxi]imino]metil]fenil}-17β-metoxi-
                           17α-(metoximetil)estra-4,9-dien-3-ona

                           C31H40N2O5

                                    H
                           H3C      N        O
                                                 N
                                                                H       CH3 OCH3
                                         O
                                                                    H         O CH3

                                                                        H
                                                     O




270
WHO Drug Information, Vol. 17, No. 4, 2003                                                      Recommended INN: List 50



 ataciguatum
 ataciguat                                   5-chloro-2-[(5-chloro-2-thienyl)sulfonylamino]-N-[4-(morpholin-
                                             4-ylsulfonyl)phenyl]benzamide

 ataciguat                                   5-chloro-2-[[(5-chlorothiophén-2-yl)sulfonyl]amino]-N-[4-(morpholin-
                                             4-ylsulfonyl)phényl]benzamide

 ataciguat                                   5-cloro-2-[(5-cloro-2-tienil)sulfonilamino]-N-[4-(morfolin-
                                             4-ilsulfonil)fenil]benzamida

                                             C21H19Cl2N3O6S3

                                                                      H
                                                                      N       O
                                             O
                                                                                  H
                                                   N                              N               Cl
                                                        S                             S     S
                                                       O O                        O O
                                                                Cl

 atazanavirum
 atazanavir                                  dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-
                                             4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-
                                             pentaazatetradecanedioate

 atazanavir                                  (3S,8S,9S,12S)-9-benzyl-3,12-bis(1,1-diméthyléthyl)-8-hydroxy-
                                             4,11-dioxo-6-[4-(pyridin-2-yl)benzyl]-2,5,6,10,13-
                                             pentaazatétradécanedioate de diméthyle

 atazanavir                                  (3S,8S,9S,12S)-9-bencil-3,12-di-terc-butil-8-hidroxi-4,11-dioxo-
                                             6-[4-(2-piridill)bencil]-2,5,6,10,13-pentaazatetradecanodioato de
                                             dimetilo

                                             C38H52N6O7


                                                                      N


                                                                CH3
                                                        H3C
                                                       O H           CH3 H OH               O
                                                                     H                            H
                                             H3C                     N        N                   N    O
                                                   O        N                           N                  CH3
                                                            H             H             H        H O
                                                                O                     H3C
                                                                                                CH3
                                                                                            CH3



 barixibatum
 barixibat                                   11-(D-gluconamido)-N-{2-[(1S,2R,3S)-3-hydroxy-3-phenyl-
                                             2-(2-pyridyl)-1-(2-pyridylamino)propyl]phenyl}undecanamide

 barixibat                                   11-(D-gluconylamino)-N-[2-[(1S,2R,3S)-3-hydroxy-3-phényl-
                                             2-(pyridin-2-yl)-1-(pyridin-2-ylamino)propyl]phényl]undécanamide

 barixibat                                   {N-[2-[(1S,2R,3S)-3-fenil-3-hidroxi-2-(piridin-2-il)-1-(piridin-
                                             2-ilamino)propil]fenil]-11-(D-gluconamido)}undecanamida




                                                                                                                    271
Recommended INN: List 50                                            WHO Drug Information, Vol. 17, No. 4, 2003




                           C42H55N5O8

                                                                O                                               O
                                                                                                                      H
                                   HO      H                N                                               N             OH
                                                            H                                               H              H
                                                        H                                                       H
                                                                                                                             OH
                                                   HN                                                           HO
                                           H                                                                     HO
                                                            N
                                               N                                                                      H
                                                                                                                            OH


 barusibanum
 barusiban                 C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-
                           L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-
                           L-ornithinol]

 barusiban                 (4S,7S,10S,13S,16R)-N-[(1S)-4-amino-1-(hydroxyméthyl)butyl]-
                           7-(2-amino-2-oxoéthyl)-16-(1H-indol-3-ylméthyl)-N-méthyl-10-[(1R)-
                           1-méthylpropyl]-13-[(1S)-1-méthylpropyl]-6,9,12,15,18-pentaoxo-
                           1-thia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
                            4.6    1
 barusibán                 C ,S -ciclo[N-(3-sulfanilpropanoil)-D-triptofil-L-isoleucil-
                           L-aloisoleucil-L-asparaginil-L-2-aminobutanoil-N-metil-L-ornitinol

                           C40H63N9O8S

                                                   CH3                              NH2
                                                            CH3             O                             OH
                                               O             H          O       H                 O        H
                                   H                              H                       H
                           O       N               H              N                       N                                NH2
                                                   N                          N                       N
                                                   H              H           H
                                       H                    O            H          O         H       CH3
                                                                        CH3
                                                                  CH3
                                  HN


                           S



 bertilimumabum
 bertilimumab              immunoglobulin G4, anti-(human eotaxin 1) (human monoclonal
                           CAT-213 γ4-chain), disulfide with human monoclonal CAT-213
                           κ-chain, dimer

 bertilimumab              immunoglobuline G4, anti-(éotaxine 1 humaine) (chaîne γ4 de
                           l’anticorps monoclonal humain CAT-213), dimère du disulfure avec
                           la chaîne κ de l’anticorps monoclonal humain CAT-213

 bertilimumab              inmunoglobulina G4, anti-(eotaxina 1 humana) (cadena γ4 del
                           anticuerpo monoclonal humano CAT-213), dímero del disulfuro con
                           la cadena κ del anticuerpo monoclonal humano CAT-213




272
WHO Drug Information, Vol. 17, No. 4, 2003                                                 Recommended INN: List 50



 bortezomibum
 bortezomib                                  {(1R)-3-methyl-1-[(2S)-3-phenyl-2-(pyrazin-2-carboxamido)=
                                             propanamido]butyl}boronic acid

 bortézomib                                  acide [(1R)-3-méthyl-1-[[(2S)-3-phényl-2-[(pyrazinylcarbonyl)amino]=
                                             propanoyl]amino]butyl]boronique

 bortezomib                                  ácido {(1R)-3-metil-1-[(2S)-3-fenil-2(pirazin-2-carboxamido)=
                                             propanamido]butil}borónico

                                             C19H25BN4O4




                                                      O                   OH
                                                          H         H
                                                N                   N     B
                                                          N                   OH
                                                          H               H
                                                                O              CH3
                                                N
                                                                          CH3


 cinacalcetum
 cinacalcet                                  N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-
                                             1-amine

 cinacalcet                                  N-[(1R)-1-(naphtalén-1-yl)éthyl]-3-[3-(trifluorométhyl)phényl]propan-
                                             1-amine

 cinacalcet                                  N-[(1R)-1-(1-naftil)etil]-3-[3-(trifluorometil)fenil]propan-
                                             1-amina

                                             C22H22F3N

                                                                  H CH3

                                                                N
                                                                H


                                                CF3


 darunavirum
 darunavir                                   (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-1-benzyl-
                                             2-hydroxy-3-(N1-isobutylsulfanilamido)propyl]carbamate

 darunavir                                   [(1S,2R)-3-[[(4-aminophényl)sulfonyl](2-méthylpropyl)amino]-
                                             1-benzyl-2-hydroxypropyl]carbamate de (3R,3aS,6aR)-
                                             hexahydrofuro[2,3-b]furan-3-yle

 darunavir                                   N-[(1S,2R)-1-bencil-2-hidroxi-3-(N-isobutilsulfanilamido)propil]=
                                             carbamato de (3R,3aS,6aR)-hexahidrofuro[2,3-b]furan-3-ilo




                                                                                                                 273
Recommended INN: List 50                                    WHO Drug Information, Vol. 17, No. 4, 2003




                           C27H37N3O7S



                                H
                            O       O
                                              O     H              O O
                                                                    S
                                 H H O             N              N
                                                   H     H OH
                                                        H3C                   NH2

                                                             CH3


 dexmethylphenidatum
 dexmethylphenidate        methyl (2R)-phenyl[(2R)-2-piperidyl]acetate

 dexméthylphénidate        (2R)-phényl[(2R)-pipéridin-2-yl]acétate de méthyle

 dexmetilfenidato          (2R)-fenil[(2R)-2-piperidiil]acetato de metilo

                           C14H19NO2

                                        O         CH3
                                    H         O


                                        H
                                         HN


 disufentonum natricum
 disufenton sodium         disodium 4-(tert-butyliminomethyl)benzene-1,3-disulfonate N-oxide

 disufenton sodique        N-oxyde de 4-[[(1,1-diméthyléthyl)imino]méthyl]benzène-
                           1,3-disulfonate de disodium

 disufentón de sodio       N-óxido de 4-terc-butiliminometil]benceno-1,3-disulfonato de disodio

                           C11H13NNa2O7S2

                           NaO3S                   SO3Na
                                                    H3C     CH3

                                                        N    CH3

                                                        O

 dofequidarum
 dofequidar                1-(diphenylacetyl)-4-[(2RS)-2-hydroxy-
                           3-(5-quinolyloxy)propyl]piperazine

 doféquidar                1-(diphénylacétyl)-4-[(2RS)-2-hydroxy-3-(quinoléin-
                           5-yloxy)propyl]pipérazine

 dofequidar                1-(difenilacetil)-4-[(2RS)-2-hidroxi-3-(quinolein-
                           5-iloxi)propil]piperazina




274
WHO Drug Information, Vol. 17, No. 4, 2003                                                                  Recommended INN: List 50



                                             C30H31N3O3


                                                             O

                                                                 N               H OH
                                                                                                             and enantiomer
                                                                             N            O                  et énantiomère
                                                                                                             y enantiómero


                                                                                                    N


 doramapimodum
 doramapimod                                 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-
                                             3-[4-(2-morpholinoethoxy)-1-naphthyl]urea

 doramapimod                                 1-[3-(1,1-diméthyléthyl)-1-(4-méthylphényl)-1H-pyrazol-5-yl]-
                                             3-[4-[2-(morpholin-4-yl)éthoxy]naphtalén-1-yl]urée

 doramapimod                                 1-[3-terc-butil-1-(4-metilfenil)-1H-pirazol-5-il]-3-[4-(2-morfolinoetoxi)-
                                             1-naftil]urea

                                             C31H37N5O3

                                             H3C       CH3

                                             H3C                                          O
                                                                     O                                  N
                                                   N
                                                                                                               O
                                                       N         N        N
                                                                 H        H




                                                 H3C


 etiprednoli dicloacetas
 etiprednol dicloacetate                     ethyl 17α-(dichloroacetoxy)-11β-hydroxy-3-oxoandrosta-1,4-diene-
                                             17β-carboxylate

 dicloacétate d’étiprednol                   17-[(dichloroacétyl)oxy]-11β-hydroxy-3-oxoandrosta-1,4-diène-
                                             17β-carboxylate d’éthyle

 dicloroacetato de etiprednol                17-[(dicloroacetil)oxi]-11β-hidroxi-3-oxoandrosta-1,4-dieno-
                                             17β-carboxilato de etilo

                                             C24H30Cl2O6

                                                                                         CH3
                                                                             O
                                                                                 O       Cl
                                                             H           CH3
                                                       HO                        O
                                                        CH3          H                         Cl
                                                                                     O
                                                             H           H
                                             O




                                                                                                                                275
Recommended INN: List 50                                       WHO Drug Information, Vol. 17, No. 4, 2003




 etravirinum
 etravirine                4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy]-
                           3,5-dimethylbenzonitrile

 étravirine                4-[[6-amino-5-bromo-2-[(4-cyanophényl)amino]pyrimidin-4-yl]oxy]-
                           3,5-diméthylbenzonitrile

 etravirina                4-[6-amino-5-bromo-2-(4-cianoanilino)pirimidin-4-iloxi]-
                           3,5-dimetilbenzonitrilo

                           C20H15BrN6O

                                                NH2
                                   Br                                 CN
                                                    N

                                    O           N         N
                                                          H
                           H3C                  CH3




                                    CN

 etriciguatum
 etriciguat                2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-
                           5-(4-pyridyl)pyrimidin-4-amine

 étriciguat                2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-
                           5-(pyridin-4-yl)pyrimidin-4-amine

 etriciguat                2-[1-(2-fluorobencil)-1H-pirazolo[3,4-b]piridin-3-il]-
                           5-(4-piridil)pirimidin-4-amina

                           C22H16FN7


                                                          NH2          N

                                                      N
                                            N
                           F                              N
                                        N


                                        N



 fipamezolum
 fipamezole                4-[(2RS)-2-ethyl-5-fluoroindan-2-yl]-1H-imidazole

 fipamézole                4-[(2RS)-2-éthyl-5-fluoro-2,3-dihydro-1H-indén-2-yl]-1H-imidazole

 fipamezol                 4-[(2RS)-2-etil-5-fluoroindan-2-il]-1H-imidazol

                           C14H15FN2

                                                          NH
                                                                and enantiomer
                                                          N     et énantiomère
                                                                y enantiómero
                           F
                                                    CH3




276
WHO Drug Information, Vol. 17, No. 4, 2003                                                       Recommended INN: List 50



 gemcabenum
 gemcabene                                   2,2,2',2'-tetramethyl-6,6'-oxydihexanoic acid

 gemcabène                                   acide 6,6'-oxybis(2,2-diméthylhexanoïque)

 gemcabeno                                   ácido 2,2,2’,2’-tetrametil-6,6'-dihexanoico

                                             C16H30O5

                                             HO2C                         O                 CO2H

                                                  H3C   CH3                          H3C   CH3


 ibrolipimum
 ibrolipim                                   diethyl {4-[(4-bromo-2-cyanophenyl)carbamoyl]benzyl}phosphonate

 ibrolipim                                   [4-[(4-bromo-2-cyanophényl)carbamoyl]benzyl]phosphonate de
                                             diéthyle

 ibrolipim                                   [4-[(4-bromo-2-cianofenil)carbamoil]bencil]fosfonato de dietilo

                                             C19H20BrN2O4P

                                                                                           CH3
                                                                                     O
                                                                                 P O
                                                              H
                                                              N                  O          CH3

                                                                O
                                             Br               CN

 iclaprimum
 iclaprim                                    5-[(2RS)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-
                                             5-ylmethyl]pyrimidine-2,4-diamine

 iclaprime                                   5-[[(2RS)-2-cyclopropyl-7,8-diméthoxy-2H-1-benzopyran-
                                             5-yl]methyl]pyrimidine-2,4-diamine

 iclaprim                                    5-[(2RS)-2-ciclopropil-7,8-dimetoxi-2H-cromen-5-ilmetil]pirimidina-
                                             2,4-diamina

                                             C19H22N4O3

                                                        NH2
                                                                              OCH3
                                                    N
                                                                                     and enantiomer
                                             H2N        N                     OCH3   et énantiomère
                                                                                     y enantiómero
                                                                      O

                                                                  H




                                                                                                                     277
Recommended INN: List 50                                    WHO Drug Information, Vol. 17, No. 4, 2003




 iosimenolum
 iosimenol                 5,5'-[propanedioylbis[(2,3-dihydroxypropyl)imino]bis[N-
                           (2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide]

 iosiménol                 5,5'-[propanedioylbis[(2,3-dihydroxypropyl)imino]bis[N-
                           (2,3-dihydroxypropyl)-2,4,6-triiodobenzène-1,3-dicarboxamide]

 iosimenol                 5,5'-[propanodioilbis[(2,3-dihidroxipropil)imino]bis[N-
                           (2,3-dihidroxipropil)-2,4,6-triiodobenceno-1,3-dicarboxamida]

                           C31H36I6N6O14

                                                    O       NH2              H2N          O

                                               I                 I           I                 I
                                  OH                                 O   O                             OH
                                           H                                                       H
                           HO              N                                                       N        OH
                                                                 N           N
                                               O        I                             I       O
                                                   HO                                     OH
                                                            OH                   OH

 latidectinum
 latidectin                mixture of components A4 and A3
                           component A4
                           (2a1S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR)-
                           6'-ethyl-2a1,20-dihydroxy-5',6,8,19-tetramethyl-17-oxo-
                              1
                           2a ,3',4',5',6,6',7,10,11,14,15,17a,20,20a-tetradecahydro-
                           2H,13H,17H-spiro[11,15-methanofuro[4,3,2-
                           pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl
                           1-[4-(methoxyacetamido)phenyl]cyclopentanecarboxylate
                           component A3
                               1
                           (2a S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR)-
                              1
                           2a ,20-dihydroxy-5',6,6',8,19-pentamethyl-17-oxo-
                              1
                           2a ,3',4',5',6,6',7,10,11,14,15,17a,20,20a-tetradecahydro-
                           2H,13H,17H-spiro[11,15-methanofuro[4,3,2-
                           pq][2,6]benzodioxacyclooctadecine-13,2'-[2H]pyran]-7-yl
                           1-[4-(methoxyacetamido)phenyl]cyclopentanecarboxylate

 latidectine               mélange des composés A4 et A3
                           composé A4
                           1-[4-[(méthoxyacétyl)amino]phényl]cyclopentanecarboxylate de
                           (2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-
                           6'-éthyl-20,20b-dihydroxy-5',6,8,19-tétraméthyl-17-oxo-
                           3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-
                           tétradécahydrospiro[11,15-méthano-2H,13H,17H-furo[4,3,2-
                           pq][2,6]benzodioxacyclooctadécine-13,2'-[2H]pyran]-7-yle
                           composé A3
                           1-[4-[(méthoxyacétyl)amino]phényl]cyclopentanecarboxylate de
                           (2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-
                           20,20b-dihydroxy-5',6,6',8,19-tétraméthyl-17-oxo-
                           3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-
                           tétradécahydrospiro[11,15-méthano-2H,13H,17H-furo[4,3,2-
                           pq][2,6]benzodioxacyclooctadécine-13,2'-[2H]pyran]-7-yle




278
WHO Drug Information, Vol. 17, No. 4, 2003                                                     Recommended INN: List 50



 latidectina                                 mezcla de los componentes A4 y A3
                                             componente A4
                                             1-[4-[(metoxiacetamido]fenil]ciclopentanocarboxilato de
                                                 1
                                             (2a S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR), -
                                                       1
                                             6'-etil-2a ,20-dihidroxi-5',6,8,19-tetrametil-17-oxo-
                                                1
                                             2a ,3',4',5',6,6',7,10,11,14,15,17a,20,20a, -tetradecahidro-
                                             2H,13H,17H-spiro[11,15-metanofuro[4,3,2-
                                             pq][2,6]benzodioxaciclooctadecino-13,2'-[2H]piran]-7-ilo
                                             componente A3
                                             1-[4-[metoxiacetamido]fenil]ciclopentanocarboxilato de
                                             (2a1S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,)-
                                             2a1,20,-dihidroxi-5',6,6',8,19-pentametil-17-oxo-
                                                1
                                             2a ,3',4',5',6,6',7,10,11,14,15,17a,20,20a,-tetradecahidro-
                                             2H,13H,17H-spiro[11,15-metano-furo[4,3,2-
                                             pq][2,6]benzodioxaciclooctadecino-13,2'-[2H]piran]-7-ilo

                                             C46H61NO11 (component A3)
                                             C47H63NO11 (component A4)

                                                                                                                        CH3
                                                                                             CH3
                                                                                         H              H                H
                                                                                     O                      O
                                                                 O                                                          H
                                                                                 O                                  O
                                                     O                                                                  R
                                             H3C                     N            H3C
                                                                     H                   H                      H
                                                                                                   O        O
                                                                                                   OH       H
                                                                 A4 : R = C2H5

                                                                 A3 : R = CH3                 O                 CH3
                                                                                                   H        H
                                                                                                       OH

 lurasidonum
 lurasidone                                  (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-
                                             1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-
                                             1,3-dione

 lurasidone                                  (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-
                                             yl)pipérazin-1-yl]méthyl]cyclohexyl]méthyl]hexahydro-4,7-méthano-
                                             2H-isoindole-1,3-dione

 lurasidona                                  3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-bencisotiazol-3-il)piperazin-
                                             1-il]metil]ciclohexil]metil]hexahidro-4,7-metano-2H-isoindol-1,3-diona

                                             C28H36N4O2S

                                                         H
                                                             H
                                                                     O

                                                                 N
                                             H   H                       H
                                                                 H
                                                     O                       N
                                                                                 N

                                                                                     N S




                                                                                                                                279
Recommended INN: List 50                                WHO Drug Information, Vol. 17, No. 4, 2003




 mantabegronum
 mantabegron               (2RS)-1-(adamantan-1-ylamino)-3-phenoxypropan-2-ol
                                                                    3,7
 mantabégron               (2RS)-1-phénoxy-3-(tricyclo[3.3.1.1 ]déc-1-ylamino)propan-2-ol
                                                              3,7
 mantabegrón               (2RS)-1-fenoxi-3-(triciclo[3.3.1.1 ]dec-1-ilamino)propan-2-ol

                           C19H27NO2

                                          H OH H
                                    O          N                and enantiomer
                                                                et énantiomère
                                                                y enantiómero



 matuzumabum
 matuzumab                 immunoglobulin G1, anti-(human epidermal growth factor receptor)
                           (humanized MAb 425 γ1 chain), disulfide with humanized MAb 425
                           κ-chain,dimer

 matuzumab                 immunoglobuline G1, anti-(récepteur du facteur de croissance
                           humain de l’épiderme) (chaîne γ1 de l’anticorps monoclonal de
                           souris 425 humanisé), dimère du disulfure avec la chaîne κ de
                           l’anticorps monoclonal de souris 425 humanisé

 matuzumab                 inmunoglobulina G1, anti-(receptor humano del factor de crecimiento
                           de la epidermis) (cadena γ1 del anticuerpo monoclonal humanizado
                           de ratón 425), dímero del disulfuro con la cadena κ del anticuerpo
                           monoclonal humanizado de ratón 425




 meclinertantum
 meclinertant              2-[[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-
                                                                3,7
                           3-yl]carbonyl]amino]tricyclo[3.3.1.1 ]decane-2-carboxylic acid

 méclinertant              acide 2-[[[1-(7-chloroquinoléin-4-yl)-5-(2,6-diméthoxyphényl)-
                           1H-pyrazol-3-yl]carbonyl]amino]tricyclo[3.3.1.13,7]décane-
                           2-carboxylique

 meclinertant              ácido 2-[[[1-(7-cloroquinolin-4-il)-5-(2,6-dimetoxifenil)-1H-pirazol-
                                                               3,7
                           3-il]carbonil]amino]triciclo[3.3.1.1 ]decano-2-carboxílico

                           C32H31ClN4O5

                           Cl             N



                                OCH3      N N
                                                    H
                                                    N      CO2H

                                        OCH3    O




280
WHO Drug Information, Vol. 17, No. 4, 2003                                                Recommended INN: List 50



 mitratapidum
 mitratapide                                 2-[(2R)-butan-2-yl]-4-(4-{4-[4-({(2S,4R)-2-(4-chlorophenyl)-
                                             2-[(4-methyl-4H-1,2,4-triazol-3-ylsulfanyl)methyl]-1,3-dioxolan-
                                             4-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-2,4-dihydro-
                                             3H-1,2,4-triazol-3-one

 mitratapide                                 4-[4-[4-[4-[[(2S,4R)-2-(4-chlorophényl)-2-[[(4-méthyl-4H-1,2,4-triazol-
                                             3-yl)sulfanyl]méthyl]-1,3-dioxolan-4-yl]méthoxy]phényl]pipérazin-
                                             1-yl]phényl]-2-[(1R)-1-méthylpropyl]-2,4-dihydro-3H-1,2,4-triazol-
                                             3-one

 mitratapida                                 2-[(2R)-butan-2-il]-4-(4-{4-[4-({2-(4-clorofenil)-2-[(2S,4R)-(4-metil-
                                             4H-1,2,4-triazol-3-ilsulfanil)metil]-1,3-ioxolan-4-il}metoxi)=
                                             fenil]piperazin-1-il}fenil)-2,4-dihidro-3H-1,2,4-triazol-3-ona

                                             C36H41ClN8O4S

                                                                                                                      Cl

                                                                                                       O
                                                   H CH3 O
                                             H3C                                                                  CH3
                                                        N                                              O
                                                             N             N     N             O   H        S     N
                                                        N
                                                                                                                N N


 oxeglitazarum
 oxeglitazar                                 (2E,4E)-5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-
                                             3-methylpenta-2,4-dienoic acid

 oxéglitazar                                 acide (2E,4E)-5-(7-méthoxy-3,3-diméthyl-2,3-dihydro-1-benzoxépin-
                                             5-yl)-3-méthylpenta-2,4-diénoïque

 oxeglitazar                                 ácido (2E,4E)-3-metil-5-(3,3-dimetil-7-metoxi-2,3-dihidro-
                                             1-benzoxepin-5-il)penta-2,4-dienoico

                                             C19H22O4

                                               H3C                 CH3
                                             H3C                         CO2H


                                                   O
                                                                 OCH3


 posizolidum
 posizolid                                   (5R)-3-(4-{1-[(2S)-2,3-dihydroxypropanoyl]-1,2,3,6-tetrahydro-
                                             4-pyridyl}-3,5-difluorophenyl)-5-(1,2-oxazol-3-yloxymethyl)-
                                             1,3-oxazolidin-2-one

 posizolid                                   (5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-1,2,3,6-tétrahydropyridin-
                                             4-yl]-3,5-difluorophényl]-5-[(isoxazol-3-yloxy)méthyl]oxazolidin-2-one

 posizolid                                   (5R)-3-(4-{1-[(2S)-2,3-dihidroxipropanoil]-1,2,3,6-tetrahidro-4-piridil}-
                                             3,5-difluorofenil)-5-[(isoxazol-3-iloxi)metil]oxazolidin-2-ona




                                                                                                                      281
Recommended INN: List 50                                       WHO Drug Information, Vol. 17, No. 4, 2003




                           C21H21F2N3O7

                                                   O       O
                                           H
                               N       O
                                                       N                  F
                           O


                                                                                           H OH
                                                                 F                    N               OH

                                                                                          O

 rafabegronum
 rafabegron                (3-{(2R)-2-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino]propyl}-
                           1H-indol-7-yloxy)acetic acid

 rafabégron                acide [[3-[(2R)-2-[[(2R)-2-(3-chlorophényl)-2-hydroxyéthyl]=
                           amino]propyl]-1H-indol-7-yl]oxy]acétique

 rafabegrón                ácido (3-{(2R)-2-[(2R)-2-(3-clorofenil)-2-hidroxetilamino]propil}-
                           1H-indol-7-iloxi)acético

                           C21H23ClN2O4

                                       H OH H
                                            N

                                                   H CH3                          O
                                                                     NH                   CO2H
                               Cl

 rupintrivirum
 rupintrivir               ethyl (2E,4S)-4-[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-(5-methyl-
                           1,2-oxazol-3-carboxamido)-4-oxoheptanamido]-
                           5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate

 rupintrivir               (2E,4S)-4-[[(2R,5S)-2-(4-fluorobenzyl)-6-méthyl-
                           5-[[(5-méthylisoxazol-3-yl)carbonyl]amino]-4-oxoheptanoyl]amino]-
                           5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-énoate d’éthyle

 rupintrivir               (2E,4S)-4-[(2R,5S)-2-(4-fluorobencil)-6-metil-5-(5-metil-1,2-isoxazol-
                           3-carboxamido)-4-oxoheptanamido]-5-[(3S)-2-oxopirrolidin-3-il]pent-
                           2-enoato de etilo

                           C31H39FN4O7

                                                                              H
                                                                              N       O

                                               H3C                                    H
                                           O    H          CH3       O        H
                                   N                                                              O    CH3
                                               N                          N
                               O               H                          H
                                                       O             H                        O
                           H3C


                                                                          F




282
WHO Drug Information, Vol. 17, No. 4, 2003                                                    Recommended INN: List 50



 sorafenibum
 sorafenib                                   4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-
                                              2
                                             N -methylpyridine-2-carboxamide

 sorafénib                                   4-[4-[[[4-chloro-3-(trifluorométhyl)phényl]carbamoyl]amino]phénoxy]-
                                             N-méthylpyridine-2-carboxamide

 sorafenib                                   4-(4-{3-[4-cloro-3-(trifluorometil)fenil]ureido}fenoxi)-
                                             N2-metilpiridina-2-carboxamida

                                             C21H16ClF3N4O3

                                                              H       H
                                                              N       N
                                                                                          N
                                                                                                   H
                                                                  O                                N
                                             Cl                                O                       CH3
                                                        CF3                                   O


 squalaminum
 squalamine                                  (24R)-3β-[3-(4-aminobutylamino)propylamino]-7α-hydroxy-
                                             5α-cholestan-24-yl hydrogen sulfate

 squalamine                                  hydrogénosulfate de (24R)-3β-[[3-[(4-aminobutyl)amino]=
                                             propyl]amino]-7α-hydroxy-5α-cholestan-24-yle

 escualamina                                 hidrógenosulfato de (24RS)-3β-[3-(4-aminobutilamino)propilamino]-
                                             7α-hidroxi-5α-colestan-24-ilo

                                             C34H65N3O5S

                                                                                                   H3C H         H
                                                                                                                     OSO3H
                                                                                                   CH3
                                                                                                             H          CH3
                                                                                      CH3      H                 H 3C

                                                                                          H        H
                                             H 2N
                                                                  N           N                    OH
                                                                  H           H H     H        H


 tacedinalinum
 tacedinaline                                4-acetamido-N-(2-aminophenyl)benzamide

 tacédinaline                                4-(acétylamino)-N-(2-aminophényl)benzamide

 tacedinalina                                4-acetamido-N-(2-aminofenil)benzamida

                                             C15H15N3O2

                                                         H
                                             H3C         N
                                                                              NH2
                                                                          H
                                                    O                     N

                                                                      O




                                                                                                                         283
Recommended INN: List 50                                WHO Drug Information, Vol. 17, No. 4, 2003




 telbivudinum
 telbivudine               1-(2-deoxy-β-L-erythro-pentofuranosyl)-5-methylpyrimidine-
                           2,4(1H,3H)-dione

 telbivudine               1-(2-désoxy-β-L-érythro-pentofuranosyl)-5-méthylpyrimidine-
                           2,4(1H,3H)-dione

 telbivudina               1-(2-desoxi-β-L-eritro-pentofuranosil)-5-metilpirimidina-
                           2,4(1H,3H)-diona

                           C10H14N2O5

                                      O
                                   OH

                           HO                  N    O

                                                   NH
                                   H3C
                                               O

 tolevamerum
 tolevamer                 poly[1-(4-sulfophenyl)ethylene]

 tolévamer                 poly[1-(4-sulfophényl)éthylène]

 tolevámero                poli[1-(4-sulfofenil)etileno]

                           (C8H8O3S)n


                                 O
                                    OH
                                O S




                                            H

                                           n
                           H




284
    WHO Drug Information, Vol. 17, No. 4, 2003                                                Recommended INN: List 50




                                 AMENDMENTS TO PREVIOUS LISTS
                         MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
                             MODIFICACIONES A LAS LISTAS ANTERIORES


    Proposed International Nonproprietary Names (Prop. INN): List 88
    Dénominations communes internationales proposées (DCI Prop.): Liste 88
    Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 88
    (WHO Drug Information, Vol. 17, No. 1, 2003)

    p. 58    lurasidonum
             lurasidone                     replace the chemical name by the following:
                                            (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-
                                            1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione

    p. 60    delete/supprimer/suprimase     insert/insérer/insértese

             mitratapidum                   mitratapidum
             mitratapid                     mitratapide
             mitratapid                     mitratapide
             mitratapid                     mitratapida



    Recommended International Nonproprietary Names (Rec. INN): List 49
    Dénominations communes internationales recommandées (DCI Rec.): Liste 49
    Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 49
    (WHO Drug Information, Vol. 17, No. 2, 2003)

    p. 118   axomadolum
             axomadol                       replace the molecular formula by the following:
             axomadol                       remplacer la formule brute par :
             axomadol                       sustitúyase la fórmula molecular por:

                                            C16H25NO3




Procedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generales
The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical
Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical
Substances will be reproduced in uneven numbers of proposed INN lists only.
Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les
substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales
applicables aux substances pharmaceutiques seront publiés seulement dans les numéros impairs des listes des DCIs
proposées.
El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias
farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para
sustancias farmacéuticas aparece solamente en los números impares de las listas de DCI propuestas.




                                                                                                                       285
Recommended INN: List 50   WHO Drug Information, Vol. 17, No. 4, 2003




286
